Dongbing Ding

688 total citations
20 papers, 509 citations indexed

About

Dongbing Ding is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dongbing Ding has authored 20 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dongbing Ding's work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Dongbing Ding is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Dongbing Ding collaborates with scholars based in China, Belarus and Uzbekistan. Dongbing Ding's co-authors include Rongpu Liang, Bo Wei, Jun Shao, Xudong Zhu, Shengxin Huang, Songbai Zhang, Xintao Shuai, Huihai Zhong, Hongbo Wei and Tufeng Chen and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Acta Biomaterialia.

In The Last Decade

Dongbing Ding

16 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongbing Ding China 12 210 179 147 140 92 20 509
Rongpu Liang China 11 179 0.9× 164 0.9× 105 0.7× 145 1.0× 97 1.1× 17 455
Jingyao Tu China 13 142 0.7× 177 1.0× 182 1.2× 108 0.8× 100 1.1× 27 466
Jared M. Newton United States 12 140 0.7× 184 1.0× 166 1.1× 97 0.7× 54 0.6× 19 424
Jiakang Jin China 8 170 0.8× 97 0.5× 140 1.0× 72 0.5× 47 0.5× 10 375
Jinti Lin China 8 170 0.8× 97 0.5× 142 1.0× 72 0.5× 47 0.5× 10 375
Shabnam Eghbali United States 4 296 1.4× 373 2.1× 179 1.2× 92 0.7× 109 1.2× 5 619
Shuiling Jin China 12 166 0.8× 216 1.2× 248 1.7× 75 0.5× 61 0.7× 36 550
Weiqiang Jing China 14 286 1.4× 193 1.1× 247 1.7× 220 1.6× 48 0.5× 23 674
Lihua Qiu China 15 163 0.8× 246 1.4× 183 1.2× 143 1.0× 103 1.1× 71 640
Feyza Gül Özbay Kurt Germany 10 287 1.4× 192 1.1× 159 1.1× 69 0.5× 36 0.4× 14 543

Countries citing papers authored by Dongbing Ding

Since Specialization
Citations

This map shows the geographic impact of Dongbing Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongbing Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongbing Ding more than expected).

Fields of papers citing papers by Dongbing Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongbing Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongbing Ding. The network helps show where Dongbing Ding may publish in the future.

Co-authorship network of co-authors of Dongbing Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Dongbing Ding. A scholar is included among the top collaborators of Dongbing Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongbing Ding. Dongbing Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Jiannan, Menglin Song, Dongbing Ding, et al.. (2025). Combined Oxaliplatin with 5-Fluorouracil for Effective Chemotherapy Against Gastric Cancer in Animal Model. International Journal of Nanomedicine. Volume 20. 7763–7780.
2.
Ding, Dongbing, Jiannan Ren, Rongpu Liang, et al.. (2025). SPP1 high macrophage-induced T-cell stress promotes colon cancer liver metastasis through SPP1/CD44/PI3K/AKT signaling. Journal for ImmunoTherapy of Cancer. 13(10). e012330–e012330.
3.
Liang, Rongpu, et al.. (2025). CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway. Cancer Immunology Immunotherapy. 74(3). 94–94.
4.
Liang, Rongpu, Dongbing Ding, Shengxin Huang, et al.. (2024). HDACi combination therapy with IDO1i remodels the tumor microenvironment and boosts antitumor efficacy in colorectal cancer with microsatellite stability. Journal of Nanobiotechnology. 22(1). 753–753. 5 indexed citations
5.
Ding, Dongbing, Rongpu Liang, Shengxin Huang, et al.. (2024). Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer. Journal of Controlled Release. 369. 309–324. 10 indexed citations
6.
Huang, Shengxin, Dongbing Ding, Jiannan Ren, et al.. (2023). Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis. Acta Biomaterialia. 164. 538–552. 42 indexed citations
7.
Shao, Jun, Wende Yang, Rui Guo, et al.. (2022). An EPO ‐loaded multifunctional hydrogel synergizing with adipose‐derived stem cells restores neurogenic erectile function via enhancing nerve regeneration and penile rehabilitation. Bioengineering & Translational Medicine. 7(3). e10319–e10319. 20 indexed citations
8.
Zhu, Xudong, Rongpu Liang, Dongbing Ding, et al.. (2022). Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. Journal for ImmunoTherapy of Cancer. 10(9). e004219–e004219. 87 indexed citations
9.
Liang, Rongpu, Xudong Zhu, Dongbing Ding, et al.. (2021). TIGIT promotes CD8+T cells exhaustion and predicts poor prognosis of colorectal cancer. Cancer Immunology Immunotherapy. 70(10). 2781–2793. 54 indexed citations
10.
Ding, Dongbing, Huihai Zhong, Rongpu Liang, et al.. (2021). Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs‐Targeting Immunotherapy of Colon Cancer. Advanced Science. 8(14). e2100712–e2100712. 91 indexed citations
11.
Shao, Jun, Rongpu Liang, Dongbing Ding, et al.. (2021). A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer. International Journal of Nanomedicine. Volume 16. 2897–2915. 43 indexed citations
12.
Shao, Jun, Xiaoming Zheng, Longbao Feng, et al.. (2020). Targeting Fluorescence Imaging of RGD-Modified Indocyanine Green Micelles on Gastric Cancer. Frontiers in Bioengineering and Biotechnology. 8. 575365–575365. 20 indexed citations
13.
Ding, Dongbing, Yao Yao, & Songbai Zhang. (2018). Duodenal mucinous adenocarcinoma presenting as ileus, obstructive jaundice and massive ascites: A case report. Molecular and Clinical Oncology. 8(3). 441–444.
14.
15.
Ding, Dongbing, Yao Yao, Changming Yang, & Songbai Zhang. (2017). Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer. Cancer Biomarkers. 21(3). 689–700. 23 indexed citations
16.
Ding, Dongbing, et al.. (2016). C-type lectins facilitate tumor metastasis. Oncology Letters. 13(1). 13–21. 26 indexed citations
17.
Zhang, Changfu, Kai Chen, Zhe Chen, et al.. (2014). The Clinical Significance of DC-SIGN and DC-SIGNR, which Are Novel Markers Expressed in Human Colon Cancer. PLoS ONE. 9(12). e114748–e114748. 40 indexed citations
18.
Chen, Zhe, Bo Wang, Chun‐Lin Chen, et al.. (2014). Activated P2X7 receptor upregulates the expression levels of NALP3 in P388D1 murine macrophage-like cells. Molecular Medicine Reports. 11(2). 1542–1546. 2 indexed citations
19.
Ding, Dongbing, Changfu Zhang, Zhe Chen, et al.. (2014). Low expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in non-Hodgkin lymphoma and a significant correlation with β2-microglobulin. Medical Oncology. 31(10). 202–202. 8 indexed citations
20.
Ding, Dongbing, et al.. (2013). Analysis of clinical characteristics, diagnosis, treatment and prognosis of 46 patients with primary gastrointestinal non-Hodgkin lymphoma. Molecular and Clinical Oncology. 2(2). 259–264. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongpu Liang Breakdown of academic impact, for papers by Jingyao Tu Breakdown of academic impact, for papers by Jared M. Newton Breakdown of academic impact, for papers by Jiakang Jin Breakdown of academic impact, for papers by Jinti Lin Breakdown of academic impact, for papers by Shabnam Eghbali Breakdown of academic impact, for papers by Shuiling Jin Breakdown of academic impact, for papers by Weiqiang Jing Breakdown of academic impact, for papers by Lihua Qiu Breakdown of academic impact, for papers by Feyza Gül Özbay Kurt
Rankless by CCL
2026